London Health Sciences Centre is a hospital network in London, Ontario and is collectively one of Canada's largest acute-care teaching hospitals. It was formed in 1995 as a result of the merger of University Hospital and Victoria Hospital.

During the past decade, London Health Sciences Centre conducted 570 clinical trials. In the 10-year time frame, 570 clinical trials started and 157 clinical trials were completed, i.e. on average, 27.5% percent of trials that started reached the finish line to date. In the past 5 years, 237 clinical trials started and 100 clinical trials were completed. i.e. 42.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "London Health Sciences Centre" #1 sponsor was "Lawson Health Research Institute" with 232 trials, followed by "Ottawa Hospital Research Institute" with 24 trials sponsored, "Western University, Canada" with 23 trials sponsored, "Ottawa Heart Institute Research Corporation" with 19 trials sponsored and "Pfizer" with 19 trials sponsored. Other sponsors include 653 different institutions and companies that sponsored additional 305 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "London Health Sciences Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 87 trials as a collaborator, "London Health Sciences Centre" with 43 trials as a collaborator, "University of Western Ontario, Canada" with 21 trials as a collaborator, "Hamilton Health Sciences Corporation" with 15 trials as a collaborator and "Medtronic" with 15 trials as a collaborator. Other collaborators include 806 different institutions and companies that were collaborators in the rest 439 trials.

According to Clinical.Site data, the most researched conditions in "London Health Sciences Centre" are "Atrial Fibrillation" (24 trials), "Crohn's Disease" (24 trials), "Prostate Cancer" (24 trials), "Ulcerative Colitis" (23 trials) and "Heart Failure" (21 trials). Many other conditions were trialed in "London Health Sciences Centre" in a lesser frequency.

Most popular intervention types in "London Health Sciences Centre" are "Drug" (469 trials), "Device" (162 trials), "Other" (137 trials), "Procedure" (116 trials) and "Behavioral" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (138 trials), "placebo" (15 trials), "Apixaban" (7 trials), "Paclitaxel" (7 trials) and "Rivaroxaban" (7 trials). Other intervention names were less common.

The vast majority of trials in "London Health Sciences Centre" are 890 trials for "All" genders, 47 trials for "Male" genders and 38 trials for "Female" genders.

Currently, there are 300 active trials in "London Health Sciences Centre". 10 are not yet recruiting, 178 are recruiting, 106 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 483 completed trials in London Health Sciences Centre, 1 suspended trials, and 85 terminated clinical trials to date.

Out of the total trials that were conducted in London Health Sciences Centre, 37 "Phase 1" clinical trials were conducted, 200 "Phase 2" clinical trials and 289 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 47 trials, and there were also 291 trials that are defined as “Not Applicable".

London Health Sciences Centre has several departments that took part in Clinical trials: "Children's Hospital" - 188 trials, "Victoria Hospital" - 87 trials, "London Regional Cancer Program 790 Commissioners Road East" - 2 trials, "London Regional Cancer Program" - 431 trials, "Division of Critical Care, Department of Pediatrics, Victoria Hospital" - 2 trials